M&T Bank Corp Roivant Sciences Ltd. Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$9.08 - $11.62 $10,723 - $13,723	1,181 Added 10.16%	12,802 $144,000
Q1 2025 Apr 30, 2025	SELL	$10.09 - $12.08 $15,871 - $19,001	-1,573 Reduced 11.92%	11,621 $117,000
Q4 2024 Feb 06, 2025	BUY	$11.16 - $12.71 $20,657 - $23,526	1,851 Added 16.32%	13,194 $156,000
Q3 2024 Nov 15, 2024	BUY	$10.17 - $12.5 $115,358 - $141,787	11,343 New	11,343 $130,000

363

463M

6.49M

1.78M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.5B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.